GEMMK
Phase 1/2 Completed
25 enrolled 15 charts
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
Phase 1/2 Completed
169 enrolled
Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
Phase 1 Completed
24 enrolled
Dendritic Cell Vaccine for Children and Adults With Sarcoma
Phase 1 Completed
19 enrolled
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
Phase 3 Completed
433 enrolled 10 charts
A Study of Surufatinib in Combination With Gemcitabine in Pediatric, Adolescent, and Young Adult Patients With Recurrent or Refractory Solid Tumors
Phase 1/2 Completed
13 enrolled 17 charts
Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma
Phase 1 Completed
36 enrolled
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
Phase 1/2 Completed
153 enrolled
A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma
Phase 2 Completed
22 enrolled 13 charts
GemTax
Phase 1/2 Completed
37 enrolled 17 charts
A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma
Phase 2 Completed
37 enrolled
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
Phase 2 Completed
54 enrolled 12 charts
A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas
Phase 2 Completed
42 enrolled 11 charts
Alimta Plus Gemcitabine for Advanced Sarcoma
Phase 2 Completed
12 enrolled 4 charts
SOURCE
Phase 2 Completed
209 enrolled 18 charts
Bevacizumab, Chemotherapy and Valproic Acid in Advanced Sarcomas
Phase 1 Completed
47 enrolled
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
Phase 1 Completed
17 enrolled
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
Phase 2 Completed
90 enrolled
A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
30 enrolled
Docetaxel, Gemcitabine and Pazopanib as Treatment for Soft Tissue Sarcoma
Phase 1/2 Completed
6 enrolled
PP-Gemcitabine & External Beam Radiation-Sarcomas
Phase 1 Completed
41 enrolled
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes
Phase 2 Completed
47 enrolled 7 charts
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma
Phase 1/2 Completed
28 enrolled
Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
Phase 1 Completed
38 enrolled
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
Phase 2 Completed
STS
Phase 2 Completed
58 enrolled
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
35 enrolled
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
Phase 2 Completed
82 enrolled
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Phase 2 Completed
54 enrolled 8 charts
Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas
Phase 2 Completed
40 enrolled
Comparison of Gemcitabine v. Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
Phase 3 Completed
120 enrolled